Patient and tumor characteristics, including age and calendar period of primary breast cancer diagnosis, tumor size, tumor grade, PR status, and Ki-67 status, did not differ significantly between those who received tamoxifen therapy and those who did not (eTable 1 in Supplement 1). This evidence concerns the gene PGR and neoplasm.